PubRank

H J Bühring

Author PubWeight™ 77.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol 1987 4.58
2 Procyclin gene expression and loss of the variant surface glycoprotein during differentiation of Trypanosoma brucei. J Cell Biol 1989 2.60
3 The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 1998 2.37
4 Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 1997 2.32
5 Cloned long-term cytolytic T-lymphocyte line with specificity for an immediate-early membrane antigen of murine cytomegalovirus. J Virol 1986 1.86
6 Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47. Blood 1999 1.77
7 The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res 2001 1.50
8 Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34(+)CD38(-) hematopoietic cells. Blood 2001 1.44
9 Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells. J Immunol 2000 1.41
10 Simultaneous expression of CD4 and CD8 antigens by a substantial proportion of resting porcine T lymphocytes. Eur J Immunol 1987 1.41
11 Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 1996 1.38
12 Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 1988 1.34
13 Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase. Blood 1997 1.30
14 Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 1992 1.28
15 Association of signal-regulatory proteins beta with KARAP/DAP-12. Eur J Immunol 2000 1.13
16 Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant. Immunobiology 1985 1.12
17 An attempt to produce "pre-T" cell hybridomas and to identify their antigens. Eur J Immunol 1986 1.10
18 Physical properties and function of phallolysin. Biochemistry 1983 1.09
19 Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med 2012 1.08
20 Monoclonal antibodies reactive with swine lymphocytes. II. Detection of an antigen on resting T cells down-regulated after activation. J Immunol 1987 1.08
21 Aged murine killer T-cell clones acquire specific cytotoxicity for P815 mastocytoma cells. Nature 1984 1.08
22 Expression and signal transduction of the FLT3 tyrosine kinase receptor. Acta Haematol 1996 1.04
23 The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer 2006 1.04
24 The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood 1996 1.03
25 Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999 1.00
26 Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol 1999 0.98
27 Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Br J Haematol 1997 0.98
28 E-cadherin is functionally involved in the maturation of the erythroid lineage. J Cell Biol 1995 0.97
29 Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Hum Pathol 2001 0.96
30 Determination of the electrophoretic mobility of chromosomes by free flow electrophoresis. I. Morphology and stability. Electrophoresis 1989 0.94
31 CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood 1998 0.93
32 CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol 2000 0.92
33 A case of bone marrow mastocytosis associated with multiple myeloma. Ann Hematol 1998 0.92
34 AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression. Leukemia 1994 0.90
35 Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer. Cancer Res 1997 0.90
36 Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1. J Cell Physiol 1994 0.89
37 Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues. Blood 2000 0.88
38 Expression of MHC class II epitopes on human T lymphocyte clones. Cell Immunol 1990 0.87
39 Upregulation of frizzled 9 in astrocytomas. Neuropathol Appl Neurobiol 2006 0.87
40 Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection. J Immunol 2001 0.87
41 Hymenoptera-venom-induced upregulation of the basophil activation marker ecto-nucleotide pyrophosphatase/phosphodiesterase 3 in sensitized individuals. Int Arch Allergy Immunol 2001 0.87
42 AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors. Blood 1999 0.86
43 Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer. Blood 1998 0.85
44 Unicellular-unilineage erythropoietic cultures: molecular analysis of regulatory gene expression at sibling cell level. Blood 1999 0.85
45 Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev 2001 0.84
46 Stable expression of clonal specificity in murine cytomegalovirus-specific large granular lymphoblast lines propagated long-term in recombinant interleukin 2. Immunobiology 1987 0.83
47 Division of human helper T cells into two sets on the basis of the induction of anti-tumor cytotoxicity by phorbol ester and calcium ionophore. Eur J Immunol 1988 0.82
48 Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 1995 0.82
49 Ex vivo manipulation of hematopoietic stem and progenitor cells. Semin Hematol 2000 0.82
50 Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells. Immunol Lett 1993 0.82
51 Generation of CD4-positive suppressor T cells from mixed lymphocyte cultures in the presence of interleukin 2 receptor antibody TU69. An in vitro model for transplantation tolerance induction. Transplantation 1987 0.81
52 Dendritic cell-based vaccines in patients with hematological malignancies. Ann N Y Acad Sci 2001 0.80
53 Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. Cytotherapy 2009 0.80
54 Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin. Exp Hematol 2000 0.80
55 The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cells. Ann N Y Acad Sci 2001 0.80
56 "Tolerization" of human T-helper cell clones by chronic exposure to alloantigen: culture conditions dictate autocrine proliferative status but not acquisition of cytotoxic potential and suppressor-induction capacity. J Mol Cell Immunol 1988 0.80
57 Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients. Int J Immunopathol Pharmacol 2008 0.80
58 Retracted Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile protein. Blood 1992 0.79
59 Limiting dilution analysis of proliferating and helper T cells in the in vivo immune response to KLH: derepression of helper T cells at moderately increased frequencies. J Mol Cell Immunol 1986 0.79
60 HLA-class II antigens on human hematopoietic progenitors. Blut 1987 0.78
61 Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis. J Neurol Neurosurg Psychiatry 1993 0.78
62 Effects of hematopoietic growth factors on interleukin 6 secretion by blast cells derived from acute myelogenous leukemia patients. Acta Haematol 1996 0.77
63 Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells. Exp Hematol 2000 0.77
64 Different signals for stimulation of proliferation and lymphokine secretion by a CD3+ WT31- cloned cytotoxic lymphocyte. Cell Immunol 1988 0.77
65 Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation. Ann N Y Acad Sci 1999 0.77
66 Lymphokine release, suppressor cell generation, cell surface markers, and cytotoxic activity in cancer patients receiving natural interleukin-2. Mol Biother 1990 0.77
67 Monoclonal antibodies to CD6 preferentially stimulate T-cell clones with gamma/delta rather than alpha/beta antigen receptors. Hum Immunol 1991 0.76
68 Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia. Ann Hematol 1992 0.76
69 Characterization of purified and ex vivo manipulated human hematopoietic progenitor and stem cells in xenograft recipients. Ann N Y Acad Sci 1999 0.76
70 Human T cell clones with gamma/delta and alpha/beta receptors are differently stimulated by monoclonal antibodies to CD2. Cell Immunol 1990 0.76
71 Membrane damage of liposomes by the mushroom toxin phallolysin. Biochim Biophys Acta 1983 0.75
72 Specific antibody response towards predicted epitopes of the epidermal growth factor receptor induced by a thermostable synthetic peptide adjuvant conjugate. Clin Exp Immunol 1989 0.75
73 Induction of "tolerance" in monoclonal human helper T lymphocyte populations during culture under conditions of chronic alloantigenic stimulation. Transplant Proc 1988 0.75
74 Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients. Cancer Immunol Immunother 1990 0.75
75 Parameters predicting response to alpha-interferon treatment in chronic hepatitis C. Hepatogastroenterology 1997 0.75
76 Cytokine modulation of interleukin 1 and tumour necrosis factor-alpha secretion from acute myelogenous leukaemia blast cells in vitro. Leuk Res 1995 0.75
77 In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatment. Ann Hematol 1991 0.75
78 Involvement of "accessory" and antigen receptor molecules in human helper T cell clone activation studied by monoclonal antibody inhibition. Hum Immunol 1989 0.75
79 Involvement of CD45 in MHC class II-allospecific cytotoxicity. Cell Immunol 1990 0.75
80 Surface antigen expression on CD34+ cord blood cells: comparative analysis by flow cytometry and limiting dilution (LD) RT-PCR of chymopapain-treated or untreated cells. Cytometry 1996 0.75
81 Ex vivo manipulations of CD34+ peripheral blood progenitor cells. Bone Marrow Transplant 1996 0.75
82 Quantitative, phenotypic, and functional evaluation of basophils in myelodysplastic syndromes. Eur J Clin Invest 2001 0.75
83 Extrathymic development and function of human T-lymphocytes from bone marrow cells in vitro. Cell Immunol 1994 0.75
84 Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cells. Int J Cancer 1998 0.75
85 Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia. Ann Hematol 1992 0.75
86 Differential expression of the HLA-B7 and the HLA-A2 gene in transfected mouse L(tk-) cells after stimulation by mouse interferon. Immunobiology 1987 0.75
87 Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: effects on cytokine production and suppressor cell status. Biotherapy 1991 0.75
88 Evolution of a CD3+CD4+ alpha/beta T-cell receptor+ mature T-cell clone from CD3-CD7+ sorted human bone marrow cells. Dev Immunol 1993 0.75
89 Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy. Cancer Immunol Immunother 1988 0.75